Xeris Pharmaceuticals Inc (XERS) — Free Cash Flow Generation Index
Xeris Pharmaceuticals Inc (XERS) has a Free Cash Flow Generation Index of 0.97x as of June 2026. Free cash flow of $8.05 Million represents 1% of operating cash flow ($8.26 Million). Explore XERS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Xeris Pharmaceuticals Inc Free Cash Flow Generation Index (2025–2025)
Historical FCF Generation Index trend for Xeris Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Xeris Pharmaceuticals Inc generate cash.
Annual Free Cash Flow Generation for Xeris Pharmaceuticals Inc (2025–2025)
Year-by-year Free Cash Flow Generation Index for Xeris Pharmaceuticals Inc. Check Xeris Pharmaceuticals Inc (XERS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.98x | $27.93 Million | $28.63 Million | $696.00K | — |